![Frank Mottola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Mottola
Chief Tech/Sci/R&D Officer at
SUPERNUS PHARMACEUTICALS, INC.
Net worth: 851 559 $ as of 2026-05-30
Profile
Frank Mottola is currently Chief Technical Operations Officer at Supernus Pharmaceuticals, Inc. since 2025.
Formerly, Mr. Mottola was Quality Director at Able Laboratories, Inc. Education includes an undergraduate degree from Rutgers State University of New Jersey in 1993, an undergraduate degree from Walden University LLC in 2009, and an MBA from Walden University LLC in 2014.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-28 | 18,440 ( 0.03% ) | 851 559 $ | 2026-05-30 |
Frank Mottola active positions
| Companies | Position | Start |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Former positions of Frank Mottola
| Companies | Position | End |
|---|---|---|
| ABLE LABORATORIES INC. | Corporate Officer/Principal | 2004-12-31 |
Training of Frank Mottola
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Able Laboratories, Inc.
 Able Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Walden University LLC
 Walden University LLC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
- Stock Market
- Insiders
- Frank Mottola
